Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RPh201 in Alzheimer's Disease
NCT03462121Phase 2Completed
- Sponsor
- Regenera Pharma
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RPh201 in Alzheimer's disease (AD), sponsored by Regenera Pharma. Started Mar 2018; status: completed.
02
Drugs
RPh201
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03462121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462121.